Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $9.50 million. The enterprise value is $1.18 million.
Important Dates
The next estimated earnings date is Monday, March 23, 2026, after market close.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.92 million shares outstanding. The number of shares has increased by 0.64% in one year.
| Current Share Class | 1.92M |
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | +0.64% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 20.14% |
| Float | 1.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.83 |
| Forward PS | 2.77 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.73.
| Current Ratio | 3.57 |
| Quick Ratio | 3.30 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -81.97% and return on invested capital (ROIC) is -38.29%.
| Return on Equity (ROE) | -81.97% |
| Return on Assets (ROA) | -32.04% |
| Return on Invested Capital (ROIC) | -38.29% |
| Return on Capital Employed (ROCE) | -81.14% |
| Weighted Average Cost of Capital (WACC) | 2.67% |
| Revenue Per Employee | $129,875 |
| Profits Per Employee | -$1.07M |
| Employee Count | 40 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.56% in the last 52 weeks. The beta is 0.92, so BOLT's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -48.56% |
| 50-Day Moving Average | 5.73 |
| 200-Day Moving Average | 5.72 |
| Relative Strength Index (RSI) | 36.94 |
| Average Volume (20 Days) | 28,714 |
Short Selling Information
The latest short interest is 1,603, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 1,603 |
| Short Previous Month | 2,541 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.11% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, BOLT had revenue of $5.20 million and -$42.68 million in losses. Loss per share was -$22.26.
| Revenue | 5.20M |
| Gross Profit | -30.07M |
| Operating Income | -44.70M |
| Pretax Income | -42.68M |
| Net Income | -42.68M |
| EBITDA | -43.24M |
| EBIT | -44.70M |
| Loss Per Share | -$22.26 |
Full Income StatementBalance Sheet
The company has $31.91 million in cash and $23.59 million in debt, with a net cash position of $8.32 million or $4.34 per share.
| Cash & Cash Equivalents | 31.91M |
| Total Debt | 23.59M |
| Net Cash | 8.32M |
| Net Cash Per Share | $4.34 |
| Equity (Book Value) | 32.10M |
| Book Value Per Share | 16.72 |
| Working Capital | 25.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.12 million and capital expenditures -$72,000, giving a free cash flow of -$47.20 million.
| Operating Cash Flow | -47.12M |
| Capital Expenditures | -72,000 |
| Free Cash Flow | -47.20M |
| FCF Per Share | -$24.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -860.38% |
| Pretax Margin | -821.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.64% |
| Shareholder Yield | -0.64% |
| Earnings Yield | -449.22% |
| FCF Yield | -496.74% |
Analyst Forecast
The average price target for BOLT is $34.00, which is 586.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $34.00 |
| Price Target Difference | 586.87% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 22.11% |
| EPS Growth Forecast (5Y) | -8.21% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
BOLT has an Altman Z-Score of -11.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.19 |
| Piotroski F-Score | 1 |
